Franklin Resources’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-149,336
| Closed | -$11.4M | – | 2729 |
|
|
2023
Q3 | $11.4M | Buy |
149,336
+14,821
| +11% | +$1.13M | 0.01% | 881 |
|
|
2023
Q2 | $8.82M | Buy |
134,515
+93,754
| +230% | +$6.15M | ﹤0.01% | 954 |
|
|
2023
Q1 | $2.44M | Hold |
40,761
| – | – | ﹤0.01% | 1305 |
|
|
2022
Q4 | $950K | Hold |
40,761
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q3 | $1.37M | Hold |
40,761
| – | – | ﹤0.01% | 1446 |
|
|
2022
Q2 | $1.08M | Sell |
40,761
-90
| -0.2% | -$2.39K | ﹤0.01% | 1519 |
|
|
2022
Q1 | $1.2M | Sell |
40,851
-4,149
| -9% | -$122K | ﹤0.01% | 1557 |
|
|
2021
Q4 | $3.85M | Hold |
45,000
| – | – | ﹤0.01% | 1301 |
|
|
2021
Q3 | $3.35M | Sell |
45,000
-5,000
| -10% | -$373K | ﹤0.01% | 1309 |
|
|
2021
Q2 | $4.67M | Buy |
+50,000
| New | +$4.67M | ﹤0.01% | 1152 |
|